These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10385091)

  • 1. Magnesium repletion therapy improved lipid metabolism in hypomagnesemic renal transplant recipients: a pilot study.
    Gupta BK; Glicklich D; Tellis VA
    Transplantation; 1999 Jun; 67(11):1485-7. PubMed ID: 10385091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined hyperlipidemia and hypertriglyceridemia in renal allograft recipients. Comparison with non-renal combined hyperlipidemic or hypertriglyceridemic patients and normal subjects.
    Somer JB; Abbott LK; Aitken JM; Elliott C
    Clin Chim Acta; 1979 Oct; 97(2-3):123-34. PubMed ID: 226288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of low-density and high-density lipoprotein subclasses in pediatric renal transplant recipients.
    Zeljkovic A; Vekic J; Spasojevic-Kalimanovska V; Jelic-Ivanovic Z; Peco-Antic A; Kostic M; Vasic D; Spasic S
    Transpl Int; 2011 Nov; 24(11):1094-102. PubMed ID: 21848901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal function and lipid metabolism in pregnant renal transplant recipients.
    Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities in the composition of serum high density lipoprotein in renal transplant recipients.
    Jung K; Neumann R; Scholz D; Nugel E
    Clin Nephrol; 1982 Apr; 17(4):191-4. PubMed ID: 7042146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Mediterranean diet on lipid levels and cardiovascular risk in renal transplant recipients.
    Barbagallo CM; Cefalù AB; Gallo S; Rizzo M; Noto D; Cavera G; Rao Camemi A; Marino G; Caldarella R; Notarbartolo A; Averna MR
    Nephron; 1999; 82(3):199-204. PubMed ID: 10395991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractional excretion of magnesium in normal subjects and in patients with hypomagnesemia.
    Elisaf M; Panteli K; Theodorou J; Siamopoulos KC
    Magnes Res; 1997 Dec; 10(4):315-20. PubMed ID: 9513927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma high-density lipoprotein concentrations in chronic-hemodialysis and renal-transplant patients.
    Bagdade JD; Albers JJ
    N Engl J Med; 1977 Jun; 296(25):1436-9. PubMed ID: 194152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of calcineurin inhibitors on low-density lipoprotein oxidation.
    Cofan F; Cofan M; Campos B; Guerra R; Campistol JM; Oppenheimer F
    Transplant Proc; 2005 Nov; 37(9):3791-3. PubMed ID: 16386540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients.
    Bayés B; Granada ML; Lauzurica R; Pastor MC; Navarro M; Bonet J; Llopis MA; Romero R
    Transplant Proc; 2005 Nov; 37(9):3808-12. PubMed ID: 16386546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Serum Uric Acid on Renal Function of Patients with Abnormal Glucose Metabolism].
    Lyu X; Liang LB; Tang GH; He H; Jia D; An ZM; Wang C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Sep; 46(5):754-8. PubMed ID: 26619551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential analysis of the lipid profile of children post-renal transplantation.
    Singh A; Tejani C; Benfield M; Tejani A
    Pediatr Transplant; 1998 Aug; 2(3):216-23. PubMed ID: 10084746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein lipid abnormalities in healthy renal transplant recipients: persistence of low HDL2 cholesterol.
    Ettinger WH; Bender WL; Goldberg AP; Hazzard WR
    Nephron; 1987; 47(1):17-21. PubMed ID: 3306427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
    Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A
    Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid relation ships in dialysis and renal transplant patients.
    Nicholls AJ; Cumming AM; Catto GR; Edward N; Engeset J
    Q J Med; 1981; 50(198):149-60. PubMed ID: 7029600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of steroid withdrawal on long-term renal allograft recipients with posttransplantation diabetes mellitus.
    Fabrega AJ; Cohan J; Meslar P; Pollak R
    Surgery; 1994 Oct; 116(4):792-7. PubMed ID: 7940180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral physiological magnesium supplementation for 6 weeks with 1 g/d magnesium oxide does not affect increased Lp(a) levels in hypercholesterolaemic subjects.
    Hoogerbrugge N; Cobbaert C; de Heide L; Birkenhäger JC
    Magnes Res; 1996 Jun; 9(2):129-32. PubMed ID: 8878009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can dietary magnesium modulate lipoprotein metabolism?
    Singh RB; Rastogi SS; Sharma VK; Saharia RB; Kulshretha SK
    Magnes Trace Elem; 1990; 9(5):255-64. PubMed ID: 2130823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyclosporine therapy on plasma lipoprotein levels.
    Ballantyne CM; Podet EJ; Patsch WP; Harati Y; Appel V; Gotto AM; Young JB
    JAMA; 1989 Jul; 262(1):53-6. PubMed ID: 2733125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.